Search
Compass Pathways PLC
CMPSAdd to Watchlist
13.620USD
+0.330+2.48%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.84BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
17
analysts
Buy
Current Rating
21.559
Target Price
+43.06%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Compass Pathways PLC
CMPS
17
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
IQVIA Holdings Inc
IQV
26
CRISPR Therapeutics AG
CRSP
26
argenx SE
ARGX
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Compass Pathways PLC's price target?
Analysts forecast that Compass Pathways PLC's price target is USD 13.00, with the highest forecast at USD 40.00 and the lowest forecast at USD 6.00.
How have Compass Pathways PLCCMPS's recent earnings per share performed?
The market expectation was USD 0.83, while Compass Pathways PLCCMPS's earnings per share (EPS) for the previous quarter was USD -0.98. EPS for the next quarter is expected at USD -0.40.
What is the analyst rating for Compass Pathways PLC?
Based on the ratings of Compass Pathways PLC's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.